CIK 0001177648 · Non-accelerated filer<br>Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 043205099
- Phone
- 617 607 0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-12 | Kieffer Tara Lynn Chief Product Strategy Officer | Shares withheld for taxes | −3,326 | $5.59 | $19K | 33,479 |
| 2025-02-12 | Rottinghaus Scott T. Chief Medical Officer | Grant or award | +9,750 | 27,668 | ||
| 2025-02-12 | Rottinghaus Scott T. Chief Medical Officer | Shares withheld for taxes | −2,861 | $5.59 | $16K | 24,807 |
| 2025-02-12 | Or Yat Sun Chief Scientific Officer | Grant or award | +9,750 | 378,859 | ||
| 2025-02-12 | Or Yat Sun Chief Scientific Officer | Shares withheld for taxes | −4,324 | $5.59 | $24K | 374,535 |
| 2025-02-12 | MELLETT PAUL J Chief Fin. & Admin Officer | Grant or award | +7,500 | 99,210 | ||
| 2025-02-12 | MELLETT PAUL J Chief Fin. & Admin Officer | Shares withheld for taxes | −3,326 | $5.59 | $19K | 95,884 |
| 2025-02-12 | Luly Jay R. President and CEO | Grant or award | +25,500 | 872,138 | ||
| 2025-02-12 | Luly Jay R. President and CEO | Shares withheld for taxes | −7,484 | $5.59 | $42K | 864,654 |
| 2025-02-12 | Luly Jay R. President and CEO | Purchase | +45,000 | $5.69 | $256K | 846,638 |
| 2024-12-06 | Kieffer Tara Lynn Chief Product Strategy Officer | Sale 10b5-1 | −2,283 | $8.06 | $18K | 29,305 |
| 2024-12-06 | Luu Brendan Chief Business Officer | Sale 10b5-1 | −2,283 | $8.06 | $18K | 36,047 |
| 2024-12-06 | Rottinghaus Scott T. Chief Medical Officer | Sale 10b5-1 | −866 | $8.06 | $7K | 17,918 |
| 2024-12-06 | Or Yat Sun Chief Scientific Officer | Sale 10b5-1 | −2,591 | $8.06 | $21K | 369,109 |
| 2024-12-06 | MELLETT PAUL J Chief Fin. & Admin Officer | Sale 10b5-1 | −2,591 | $8.06 | $21K | 91,710 |
| 2024-12-06 | Luly Jay R. President and CEO | Sale 10b5-1 | −5,142 | $8.06 | $41K | 801,638 |
| 2024-12-01 | Luu Brendan Chief Business Officer | Shares withheld for taxes | −753 | $8.60 | $6K | 38,330 |
| 2024-12-01 | Kieffer Tara Lynn Chief Product Strategy Officer | Shares withheld for taxes | −753 | $8.60 | $6K | 31,588 |
| 2024-12-01 | Or Yat Sun Chief Scientific Officer | Shares withheld for taxes | −1,595 | $8.60 | $14K | 371,700 |
| 2024-12-01 | MELLETT PAUL J Chief Fin. & Admin Officer | Shares withheld for taxes | −1,595 | $8.60 | $14K | 94,301 |
Page 4 of 7 · 135 trades